Michael Kotsanis and his team just can’t seem to pick a winner when it comes to generic drug selection. They look all professional, say all the right things, seem to have the right experience and education, are articulate and well presented BUT IT NEVER works out. When are they going to say to themselves that they just can’t seem to succeed and it’s time for somebody else to take the company forward. The revenue is pitiful.
Add to My Watchlist
What is My Watchlist?
